Skip to main content
. 2023 Sep 21;18(9):e0291024. doi: 10.1371/journal.pone.0291024

Fig 4. The ROC curve analysis of CDCA2 in pan-cancer (AUC > 0.9).

Fig 4

(A) BLCA; (B) BRCA; (C) CESC; (D) CHOL; (E) COAD; (F) ESCA; (G) GBM; (H) KIRC; (I) LAML; (J) LGG; (K) LIHC; (L) LUAD; (M) LUSC; (N) OV; (O) OSCC; (P) PAAD; (Q) READ; (R) STAD; (S) UCEC; (T) UCS.